ﺑﺎﺯﮔﺸﺖ ﺑﻪ ﺻﻔﺤﻪ ﻗﺒﻠﯽ
خرید پکیج
تعداد آیتم قابل مشاهده باقیمانده : -14 مورد

Choice of antibiotic agent for treatment and prophylaxis of acute rheumatic fever

Choice of antibiotic agent for treatment and prophylaxis of acute rheumatic fever
Scenario Antibiotic choice(s)
Preferred treatment in endemic areas where IM penicillin is available at low cost
  • IM penicillin G benzathine given every 28 days
Alternative treatment in nonendemic areas where IM penicillin is unavailable or prohibitively expensive
  • Oral penicillin V
Confirmed penicillin allergy*
  • Preferred – Oral azithromycin
  • Alternative – Oral sulfadiazine
Severe symptomatic RHD
  • Preferred – Oral penicillin V
  • Alternatives – Oral azithromycin or oral sulfadiazine
Bleeding problems following IM injection that cannot be addressed
  • Preferred – Oral penicillin V
  • Alternatives – Oral azithromycin or oral sulfadiazine
Other barriers to using the preferred treatment that cannot be resolvedΔ
  • Oral penicillin V
Patients at low risk of recurrence◊
  • Oral penicillin V
Breakthrough infection while on prophylaxis
  • For treatment of acute infection – Oral clindamycin§
  • For ongoing prophylaxis – IM penicillin G benzathine given every 21 days
This table summarizes our suggested approach to selecting an antibiotic agent for treatment and prophylaxis of ARF. Patients who have had ARF who subsequently develop GAS infections are at high risk for a recurrent ARF attack, which increases the risk of developing more severe RHD. GAS infection need not be symptomatic to trigger a recurrent attack of ARF. Thus, the most effective method to limit progression of RHD is prevention of recurrent GAS infections. IM penicillin G benzathine is the preferred agent for treatment and prophylaxis of ARF in most cases. However, in select circumstances, an alternative agent may be appropriate, as summarized above. For additional details, refer to UpToDate topics on ARF and RHD.

ARF: acute rheumatic fever; EF: ejection fraction; GAS: Group A Streptococcus; IM: intramuscular; NYHA: New York Heart Association; RHD: rheumatic heart disease.

* Penicillin allergy should be verified by history and confirmed with testing by an allergy specialist if available before choosing an alternative to penicillin G benzathine.

¶ This includes patients with severe symptomatic valvular disease, NYHA class III or IV heart failure symptoms, and/or ventricular dysfunction (ie, EF <50%). Oral therapy is preferred for these patients because they can experience vasovagal reactions with IM injections, and this may increase the risk of sudden death.

Δ Additional barriers include patient concerns (eg, extreme needle phobia) that persist despite appropriate counseling and reassurance.

◊ Patients at low risk of recurrence include those who have reached young adulthood and have remained free of ARF attacks for several years.

§ Rates of resistance to clindamycin are high and can be higher than rates of resistance to macrolides. Therefore, when beta-lactams and macrolides cannot be used, knowledge of local resistance rates should guide antibiotic selection or culture with susceptibility testing should be obtained.
Graphic 138985 Version 2.0